Top Vaccines companies in Netherlands by Capital Expenditure

This ranking features the top 5 Vaccines companies in Netherlands ranked by Capital Expenditure, totaling a Capital Expenditure of USD -48.65 M, for February 07, 2025.
#
Name
Capital Expenditure
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD -43.81 M
Dec. 31, 2023 USD 662.53 -0.67%

Netherlands

2
USD -3.98 M
Dec. 31, 2023 USD 40.94 -1.52%

Netherlands

3
USD -730.00 K
Dec. 31, 2023 USD 0.98 -1.01%

Netherlands

4
USD -99.32 K
Dec. 31, 2023 USD 17.60 -0.73%

Netherlands

5
USD -24.00 K
Dec. 31, 2023 USD 22.29 2.39%

Netherlands

Frequently Asked Questions
  • Which Vaccines company in Netherlands has the highest Capital Expenditure ?

    The Vaccines company in Netherlands with the highest Capital Expenditure is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD -43.81 M.

  • Which Vaccines company in Netherlands has the lowest Capital Expenditure ?

    The Vaccines company in Netherlands with the lowest Capital Expenditure is NewAmsterdam Pharma Company N.V. (NasdaqGM: NAMS) at USD -24.00 K.

SV Wall Street